亚太地区测序试剂市场预测至 2028 年 - COVID-19 影响和区域分析(按技术(下一代测序、桑格测序和第三代测序)、应用(农业基因组学和法医学、临床调查、肿瘤学、生殖健康和其他应用)) 、试剂类型(对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型)和最终用户(医院和诊所、研究机构、制药和生物技术公司以及其他最终用户)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 168    |    Report Code: TIPRE00022822    |    Category: Life Sciences

Asia Pacific Sequencing Reagents Market

市场介绍

测序过程中会用到测序试剂。这些试剂的使用很大程度上取决于要获得的所需结果。它们构成了测序反应的重要组成部分,也可用于各种其他应用。

 

市场概况与动态

< p>亚太测序试剂市场预计将从2021年的13.9213亿美元增至2028年的33.3010亿美元;预计2021年至2028年复合年增长率为13.3%。市场的增长归因于对第三代测序和个性化药物的需求不断增加。然而,熟练专业人员的缺乏阻碍了市场的增长。

过去几年,基因组测序技术彻底改变了遗传疾病的突变检测。近年来,第三代测序(TGS)凭借单分子、实时测序技术,不断深入了解更多的遗传疾病。其中一项新技术由 Pacific Biosciences 开发,称为实时单分子测序 (SMRT)。 SMRT 非常高效,这意味着必须使用更少的昂贵化学品。它也非常敏感,使科学家能够有效地“窃听”信息。 DNA 聚合酶并观察它形成 DNA 链。对第三代测序(TGS)技术的需求增加归因于该领域利润丰厚的增长率。随着 TGS 的出现,基因组测序已成为研究基因组变异的更快、更可靠的方法。此外,个性化医疗提供了最有希望的治疗疾病的方法,而这些疾病一直无法得到有效的治疗或治愈。越来越多地采用利用患者遗传信息进行疾病治疗的个性化药物预计将有助于提供有针对性的治疗。反过来,预计这将在预测期内为测序试剂市场创造利润丰厚的增长机会。

亚太地区受到 COVID-19 大流行的不利影响。基因组学有助于了解 SARS-CoV-2,使政府和研究人员能够追踪本国新冠肺炎 (COVID-19) 疫情的出现。医疗保健专家意识到基因组学在治疗 COVID-19 中的重要性,预计这将在预测期内增加对基因组学的需求。因此,针对导致 COVID-19 的新型冠状病毒的研究活动不断增加,为初创企业和老牌企业的潜在机会铺平了道路。例如,印度孟买的一家初创公司 Haystack Analytics 正在利用基因组学研究冠状病毒的传播,以帮助印度政府。因此,由于 COVID-19 病例的增加,对基因组学的需求正在增加。因此,对测序试剂的需求不断增长,从而推动了市场的增长。

 

主要细分市场

亚太测序试剂市场按技术划分为二代测序、桑格测序和三代测序。下一代测序细分市场在 2020 年占据最大市场份额。然而,预计桑格测序细分市场在预测期内的复合年增长率最高。

亚太地区测序试剂市场按试剂类型分为对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型。测序试剂盒细分市场在 2020 年占据最大市场份额,而文库试剂盒细分市场预计在预测期内将实现最高的复合年增长率。

亚洲太平洋测序试剂市场按应用细分为农业基因组学和法医学、临床研究、肿瘤学、生殖健康和其他应用。肿瘤学领域在 2020 年占据了最大的市场份额。然而,预计临床研究领域在预测期内的市场复合年增长率最高。

 

主要来源和列出的公司

一些与本亚太测序试剂市场报告相关的主要和次要来源是日本医学研究与发展机构 (AMED)、基因组学健康未来使命和世界卫生组织 (WHO)。

 

购买报告的理由

  • 根据未来几年亚太测序试剂市场的详细趋势分析确定潜在投资领域。 span>
  • 深入了解推动支出最高国家不同成瘾治疗药物细分市场需求的根本因素,并确定他们各自提供的机会。
  • 加强您对市场需求驱动因素、行业趋势和最新技术发展等方面的了解。
  • 确定推动亚太地区测序试剂市场的主要渠道提供未来机遇的清晰蓝图这将有助于分析,从而扩大收入。
  • 通过关注不同国家/地区正在进行的项目来引导资源 亚太测序试剂市场

 

亚太地区测序试剂市场细分

按技术划分

  • 下一代测序
  • 桑格测序
  • 第三代测序

按试剂类型

  • 对照试剂盒
  • 文库试剂盒
  • 模板试剂盒
  • 测序试剂盒
  • 其他试剂类型

按应用

  • 农业基因组学和法医学< /span>
  • 临床研究
  • 肿瘤学
  • 生殖健康
  • 其他应用程序

最终用户

  • 医院和诊所
  • 研究机构
  • 制药和生物技术公司
  • 其他最终用户

按国家/地区

  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国
  • 亚太地区其他地区< /span>

公司简介

  • 加州太平洋生物科学公司
  • QIAGEN
  • Takara Bio Inc.
  • Thermo FISHER SCIENTIFIC INC.
  • TriLink BioTechnologies Inc
  • 华大基因
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • FLUIDIGM CORPORATION
  • LGC 生物搜索技术


Asia Pacific Sequencing Reagents Strategic Insights

Strategic insights for Asia Pacific Sequencing Reagents involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-sequencing-reagents-market-strategic-framework.webp
Get more information on this report

Asia Pacific Sequencing Reagents Report Scope

Report Attribute Details
Market size in 2021 US$ 1,392.13 Million
Market Size by 2028 US$ 3,330.10 Million
Global CAGR (2021 - 2028) 13.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 技术
  • 下一代测序
  • 桑格测序
  • 第三代测序
By 应用
  • 农业基因组学和法医学
  • 临床研究
  • 肿瘤学
  • 生殖健康
  • 其他应用
By 试剂类型
  • 对照试剂盒
  • 文库试剂盒
  • 模板试剂盒
  • 测序试剂盒
  • 其他试剂类型
By 最终用户
  • 医院和诊所
  • 研究机构
  • 制药和生物技术公司
  • 其他最终用户
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Pacific Biosciences of California, Inc.
  • QIAGEN
  • Takara Bio Inc.
  • THERMO FISHER SCIENTIFIC INC.
  • TriLink BioTechnologies Inc
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • FLUIDIGM CORPORATION
  • LGC Biosearch Technologies
  • Get more information on this report

    Asia Pacific Sequencing Reagents Regional Insights

    The regional scope of Asia Pacific Sequencing Reagents refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-sequencing-reagents-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Sequencing Reagents Market

    1. Pacific Biosciences of California, Inc.
    2. QIAGEN
    3. Takara Bio Inc.
    4. THERMO FISHER SCIENTIFIC INC.
    5. TriLink BioTechnologies Inc
    6. BGI
    7. F. HOFFMANN-LA ROCHE LTD.
    8. Illumina, Inc.
    9. FLUIDIGM CORPORATION
    10. LGC Biosearch Technologies
    11.  
    Frequently Asked Questions
    How big is the Asia Pacific Sequencing Reagents Market?

    The Asia Pacific Sequencing Reagents Market is valued at US$ 1,392.13 Million in 2021, it is projected to reach US$ 3,330.10 Million by 2028.

    What is the CAGR for Asia Pacific Sequencing Reagents Market by (2021 - 2028)?

    As per our report Asia Pacific Sequencing Reagents Market, the market size is valued at US$ 1,392.13 Million in 2021, projecting it to reach US$ 3,330.10 Million by 2028. This translates to a CAGR of approximately 13.3% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Sequencing Reagents Market report typically cover these key segments-

  • 技术 (下一代测序, 桑格测序, 第三代测序)
  • 应用 (农业基因组学和法医学, 临床研究, 肿瘤学, 生殖健康, 其他应用)
  • 试剂类型 (对照试剂盒, 文库试剂盒, 模板试剂盒, 测序试剂盒, 其他试剂类型)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Sequencing Reagents Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Sequencing Reagents Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Sequencing Reagents Market?

    The Asia Pacific Sequencing Reagents Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Pacific Biosciences of California, Inc.
  • QIAGEN
  • Takara Bio Inc.
  • THERMO FISHER SCIENTIFIC INC.
  • TriLink BioTechnologies Inc
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • FLUIDIGM CORPORATION
  • LGC Biosearch Technologies
  • Who should buy this report?

    The Asia Pacific Sequencing Reagents Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Sequencing Reagents Market value chain can benefit from the information contained in a comprehensive market report.